The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The urinalysis market has experienced robust growth, with the market size increasing from $3.3 billion in 2023 to $3.55 billion in 2024, representing a CAGR of 7.5%. Key factors contributing to this growth include:

• Rising healthcare expenditure
• Healthcare infrastructure development
• Regulatory changes and standardization
• Drug screening and forensics
• Clinical laboratory practices

The forecast period anticipates continued strong growth, reaching $4.91 billion in 2028, driven by:

• Point-of-care testing (POCT)
• Chronic disease management
• Aging population demographics
• Preventive healthcare initiatives
• Remote monitoring and telemedicine

Integration Of Artificial Intelligence In Urinalysis Devices For Technological Advancements

Technological advancements play a pivotal role in shaping the urinalysis market. Companies are increasingly integrating artificial intelligence (AI) technology into urine analysis devices to enhance efficiency and accuracy. For example:

• Olive Diagnostics introduced Olive KG, an AI-powered urinalysis sensor device providing real-time health alerts and early disease detection.
• io Ltd.’s acquisition of Inui Health strengthens its position in the smartphone diagnostic market, leveraging at-home urinalysis via smartphone.

Segmentation of the Urinalysis Market

The market is segmented based on:

1. Test Type: Pregnancy and Fertility Tests, Biochemical Urinalysis, Sediment Urinalysis
2. Product: Consumables, Instruments
3. Application: Urinary tract infections (UTI’s), Kidney Disease, Liver Disease, Diabetes, Hypertension, Other Applications
4. End Users: Diagnostic Laboratories, Hospitals and Clinics, Home Care Settings, Research Laboratories and Institutes

Regional Dynamics

North America emerged as the largest region in the urinalysis market in 2023.

The rising geriatric population significantly contributes to the growth of the urinalysis market. By 2030, the World Health Organization estimates that one in six people globally will be aged 60 or older, totaling 1.4 billion individuals. Aging populations are more susceptible to urinary tract infections (UTIs) and other urinary-related conditions, driving the demand for urinalysis.

Key players in the market include Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., Cardinal Health Inc., Abbott Laboratories, and Danaher Corporation, among others. These companies are instrumental in developing innovative solutions and advancing the capabilities of urinalysis technology.

In conclusion, the urinalysis market is experiencing significant growth fueled by technological advancements and the rising prevalence of urinary-related conditions, particularly among the geriatric population. Integration of AI and smartphone diagnostics are shaping the future of urinalysis, offering personalized and efficient healthcare solutions. As healthcare systems prioritize preventive care and remote monitoring, the urinalysis market is poised for continued expansion, catering to the evolving needs of patients and healthcare providers alike.

View More On The Urinalysis Market Report 2024 – https://www.thebusinessresearchcompany.com/report/urinalysis-global-market-report

Request A Sample Of The Global Urinalysis Market Report 2024:

https://www.thebusinessresearchcompany.com/sample_request?id=8623&type=smp